Related Experiment Videos
Photodynamic therapy of malignant brain tumors: clinical and neuropathological results
Photochemistry and Photobiology
|November 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A Third Type of Resistance to Cydia pomonella Granulovirus in Codling Moths Shows a Mixed Z-Linked and Autosomal Inheritance Pattern.
Applied and environmental microbiology·2017
Evidence for a Second Type of Resistance against Cydia pomonella Granulovirus in Field Populations of Codling Moths.
Applied and environmental microbiology·2016
Cervical spondylolisthesis C6-C7 in a young wrestler: case report.
Zentralblatt fur Neurochirurgie·2008
Rapid emergence of baculovirus resistance in codling moth due to dominant, sex-linked inheritance.
Science (New York, N.Y.)·2007
Protection against ultraviolet-A and -B with systemic nicotinamide and Polypodium leucotomos extract-A narrative review.
Photochemistry and photobiology·2026
Combined effects of photobiomodulation and platelet-rich plasma on healing of acute Achilles tendon injuries in rats.
Photochemistry and photobiology·2026
VUV and mid-UV photoabsorption cross sections of thin films of glycine and alanine: Application to their photochemistry in the solar system.
Photochemistry and photobiology·2026
Validated computational modeling to evaluate spatial inactivation of airborne pathogens by Far-UVC irradiation.
Photochemistry and photobiology·2026
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026